• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单核细胞在抗磷脂综合征发病机制中的作用及潜在治疗靶点(综述)

Role of monocytes in the pathogenesis of antiphospholipid syndrome and potential therapeutic targets (Review).

作者信息

Huo Rongxiu, Wei Chengcheng, Yang Yanting, Yang Yang, Huo Xiaocong, Wang Bangqin, Meng Danli, Huang Yijia, Huang Rongjun, Lin Jinying, Huang Xinxiang

机构信息

Department of Rheumatology and Immunology, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region 530016, P.R. China.

出版信息

Mol Med Rep. 2025 Nov;32(5). doi: 10.3892/mmr.2025.13670. Epub 2025 Sep 5.

DOI:10.3892/mmr.2025.13670
PMID:40910223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12426590/
Abstract

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized primarily by arterial and/or venous thrombosis, obstetric complications and persistent positivity for antiphospholipid antibodies (aPLs). It has been proposed that the pathogenesis of APS is closely associated with vascular endothelial cell activation, complement activation and platelet activation. Notably, APS may be key to understanding the relationship between innate immune cells, and thrombosis and obstetric complications. Monocytes are activated by aPLs, adopting a pro‑inflammatory and pro‑coagulant phenotype, and producing inflammatory cytokines; however, the exact mechanisms of action of monocytes in APS remain unclear. Monocytes may act as an intermediary, triggering immune dysregulation, closely linking them to thrombosis and obstetric complications. Therefore, a better understanding of the potential pathogenic role of monocytes in APS is required, which could assist clinicians in gaining deeper insights into the pathogenesis of APS and identifying new therapeutic targets. This may provide new options for the management of APS. Therefore, the present study aimed to review monocytes and their role in APS.

摘要

抗磷脂综合征(APS)是一种自身免疫性疾病,主要特征为动脉和/或静脉血栓形成、产科并发症以及抗磷脂抗体(aPLs)持续呈阳性。有人提出,APS的发病机制与血管内皮细胞活化、补体活化和血小板活化密切相关。值得注意的是,APS可能是理解天然免疫细胞与血栓形成及产科并发症之间关系的关键。单核细胞被aPLs激活,呈现促炎和促凝表型,并产生炎性细胞因子;然而,单核细胞在APS中的具体作用机制仍不清楚。单核细胞可能作为一种中介,引发免疫失调,将它们与血栓形成和产科并发症紧密联系起来。因此,需要更好地了解单核细胞在APS中的潜在致病作用,这有助于临床医生更深入地了解APS的发病机制并确定新的治疗靶点。这可能为APS的管理提供新的选择。因此,本研究旨在综述单核细胞及其在APS中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef1/12426590/d0e7d2c3e9e2/mmr-32-05-13670-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef1/12426590/828554cb8872/mmr-32-05-13670-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef1/12426590/47c7fc8cd039/mmr-32-05-13670-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef1/12426590/d0e7d2c3e9e2/mmr-32-05-13670-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef1/12426590/828554cb8872/mmr-32-05-13670-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef1/12426590/47c7fc8cd039/mmr-32-05-13670-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef1/12426590/d0e7d2c3e9e2/mmr-32-05-13670-g02.jpg

相似文献

1
Role of monocytes in the pathogenesis of antiphospholipid syndrome and potential therapeutic targets (Review).单核细胞在抗磷脂综合征发病机制中的作用及潜在治疗靶点(综述)
Mol Med Rep. 2025 Nov;32(5). doi: 10.3892/mmr.2025.13670. Epub 2025 Sep 5.
2
Criteria and non-criteria anti-phospholipid antibodies in the different clinical forms of antiphospholipid syndrome.抗磷脂综合征不同临床类型中的标准和非标准抗磷脂抗体
Front Immunol. 2025 Aug 1;16:1636171. doi: 10.3389/fimmu.2025.1636171. eCollection 2025.
3
NK cell dysfunction in antiphospholipid syndrome.抗磷脂综合征中的自然杀伤细胞功能障碍。
Front Immunol. 2025 Jun 12;16:1593705. doi: 10.3389/fimmu.2025.1593705. eCollection 2025.
4
Management of antiphospholipid antibody syndrome: a systematic review.抗磷脂抗体综合征的管理:一项系统综述。
JAMA. 2006 Mar 1;295(9):1050-7. doi: 10.1001/jama.295.9.1050.
5
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.抗血小板和抗凝药物用于抗磷脂抗体个体血栓形成的一级预防。
Cochrane Database Syst Rev. 2018 Jul 13;7(7):CD012534. doi: 10.1002/14651858.CD012534.pub2.
6
Thrombotic Antiphospholipid Syndrome: Recurrent Thromboses.血栓形成性抗磷脂综合征:复发性血栓形成
Dokl Biochem Biophys. 2025 May 11. doi: 10.1134/S1607672925700152.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Long-Term Follow-Up of Patients With Positive Antiphospholipid Antibodies After Fetal Death: Five Typical Cases From a Prospective Cohort Study.胎儿死亡后抗磷脂抗体阳性患者的长期随访:一项前瞻性队列研究中的五个典型病例
Immun Inflamm Dis. 2025 Feb;13(2):e70158. doi: 10.1002/iid3.70158.
9
MOLECULAR MECHANISMS OF OBSTETRIC ANTIPHOSPHOLIPID SYNDROME.
Georgian Med News. 2025 Jun(363):131-144.
10
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.抗凝血酶原 (aPT) 和抗磷脂酰丝氨酸/凝血酶原 (aPS/PT) 抗体与抗磷脂综合征中的血栓形成风险。系统评价。
Thromb Haemost. 2014 Feb;111(2):354-64. doi: 10.1160/TH13-06-0509. Epub 2013 Oct 31.

本文引用的文献

1
Pathways regulating the levels of tissue factor-positive extracellular vesicles and activation of coagulation in endotoxemic mice.调节内毒素血症小鼠组织因子阳性细胞外囊泡水平及凝血激活的信号通路。
J Thromb Haemost. 2025 Apr 24. doi: 10.1016/j.jtha.2025.04.012.
2
Monocytes and macrophages: Origin, homing, differentiation, and functionality during inflammation.单核细胞与巨噬细胞:炎症过程中的起源、归巢、分化及功能
Heliyon. 2024 Apr 15;10(8):e29686. doi: 10.1016/j.heliyon.2024.e29686. eCollection 2024 Apr 30.
3
Coenzyme Q10 and Autoimmune Disorders: An Overview.
辅酶Q10与自身免疫性疾病:概述
Int J Mol Sci. 2024 Apr 22;25(8):4576. doi: 10.3390/ijms25084576.
4
From Biomarkers to the Molecular Mechanism of Preeclampsia-A Comprehensive Literature Review.从生物标志物到子痫前期的分子机制——全面文献综述。
Int J Mol Sci. 2023 Aug 26;24(17):13252. doi: 10.3390/ijms241713252.
5
2023 ACR/EULAR antiphospholipid syndrome classification criteria.2023 年 ACR/EULAR 抗磷脂综合征分类标准。
Ann Rheum Dis. 2023 Oct;82(10):1258-1270. doi: 10.1136/ard-2023-224609. Epub 2023 Aug 28.
6
Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis.补体因子 H 通过细胞自主调控补体 C3 限制巨噬细胞噬作用并加剧动脉粥样硬化。
Immunity. 2023 Aug 8;56(8):1809-1824.e10. doi: 10.1016/j.immuni.2023.06.026. Epub 2023 Jul 26.
7
Monocyte-endothelial cell interactions in vascular and tissue remodeling.单核细胞-内皮细胞相互作用与血管和组织重构。
Front Immunol. 2023 Jul 7;14:1196033. doi: 10.3389/fimmu.2023.1196033. eCollection 2023.
8
The role of monocytes in thrombotic diseases: a review.单核细胞在血栓形成性疾病中的作用:综述
Front Cardiovasc Med. 2023 Jun 2;10:1113827. doi: 10.3389/fcvm.2023.1113827. eCollection 2023.
9
Evaluation of the relationship between monocyte to high-density lipoprotein cholesterol ratio and thrombus burden in patients with deep vein thrombosis.评价单核细胞/高密度脂蛋白胆固醇比值与深静脉血栓患者血栓负荷的关系。
Rev Assoc Med Bras (1992). 2023 Apr 14;69(4):e20221211. doi: 10.1590/1806-9282.20221211. eCollection 2023.
10
Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management.抗磷脂综合征:诊断、发病机制及管理方面的进展
BMJ. 2023 Feb 27;380:e069717. doi: 10.1136/bmj-2021-069717.